Monte Rosa Therapeutics Inc (GLUE)

Jul 23, 2025

What drives Monte Rosa Therapeutics Inc. stock priceFree Trend-Following Techniques - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Is Monte Rosa Therapeutics Inc. a good long term investmentFree Trading Strategy Suggestions - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Monte Rosa Therapeutics Inc. Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What analysts say about Monte Rosa Therapeutics Inc. stockExplosive returns - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Monte Rosa Therapeutics Announces First Subjects Dosed in - GlobeNewswire

Jul 21, 2025

Jul 21, 2025

Monte Rosa Therapeutics and the Breakthrough Potential of MRT-8102 in Inflammatory Disease Treatment - AInvest

Jul 21, 2025

Jul 21, 2025

Monte Rosa begins phase 1 trial of NEK7-targeting molecular glue degrader - Investing.com

Jul 21, 2025

Jul 21, 2025

Monte Rosa Therapeutics Announces First Subjects Dosed in Phase 1 Study of MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases - GlobeNewswire

Jul 21, 2025

Jul 21, 2025

First-Ever NEK7 Degrader Enters Clinical Trials: Monte Rosa's Novel Approach Targets Multiple Inflammatory Diseases - Stock Titan

Jul 21, 2025

Jul 18, 2025

Monte Rosa (GLUE) Soars 13.58% in Three Days, Hits 2025 High - AInvest

Jul 18, 2025

Jul 18, 2025

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Shares Fly 29% But Investors Aren't Buying For Growth - simplywall.st

Jul 18, 2025

Jul 17, 2025

Monte Rosa Therapeutics Inc (GLUE) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 17, 2025

Jul 16, 2025

How Monte Rosa Therapeutics Inc. stock performs during market volatilityPredictable High Return Trades - beatles.ru

Jul 16, 2025

Jul 15, 2025

What makes Monte Rosa Therapeutics Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025

Jul 15, 2025

Why Monte Rosa Therapeutics Inc. stock attracts strong analyst attention2x 3x 5x Pick Alert - Newser

Jul 15, 2025

Jul 15, 2025

With surface mimicry, molecular glues shed hairpin need - BioWorld MedTech

Jul 15, 2025

Jul 09, 2025

Monte Rosa Therapeutics (GLUE) Soars 4.55% on Clinical Trial Progress - AInvest

Jul 09, 2025

Jul 04, 2025

Monte Rosa Therapeutics (GLUE): Pioneering the Future of Drug Discovery with Molecular Glue Degraders - AInvest

Jul 04, 2025

Jul 03, 2025

Monte Rosa Therapeutics Announces Publication of Landmark Research on Molecular Glue Degraders in Science - Nasdaq

Jul 03, 2025

Jul 03, 2025

Monte Rosa Announces Publication in Science of Key Insights - GlobeNewswire

Jul 03, 2025

Jul 03, 2025

Monte Rosa Announces Publication in Science of Key Insights That Enable Next Generation Molecular Glue Degrader Medicines - MarketScreener

Jul 03, 2025

Jul 03, 2025

Monte Rosa's AI Discovery Unlocks 100+ New Drug Targets, Featured in Science Magazine Cover Story - Stock Titan

Jul 03, 2025

Jun 14, 2025

Monte Rosa gets FDA clearance to begin testing MRT-8102 - MSN

Jun 14, 2025

Jun 12, 2025

FMR LLC Reduces Stake in Monte Rosa Therapeutics Inc. - GuruFocus

Jun 12, 2025

Jun 12, 2025

Bank of America Corp DE Reduces Stock Holdings in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) - Defense World

Jun 12, 2025

Jun 11, 2025

Monte Rosa’s molecular glue degrader MRT-8102 gains IND clearance for inflammatory conditions - BioWorld MedTech

Jun 11, 2025